(Q37169758)

18 August 2017

Skin-lightening products revisited (English)

1 reference

18 August 2017

L Petit

1

1 reference

PubMed ID

18494898

18 August 2017

G E Piérard

series ordinal

2

1 reference

18 August 2017

1 August 2003

1 reference

International Journal of Cosmetic Science

18 August 2017

1 reference

18 August 2017

25

1 reference

18 August 2017

4

1 reference

18 August 2017

169-181

1 reference

EEMCO guidance for the assessment of skin colour

18 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Pigmentary changes in aged and photoaged skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Peroxidase-mediated mechanisms are involved in the melanocytotoxic and melanogenesis-inhibiting effects of chemical agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

The role of melanocortins in skin homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Histamine induces melanogenesis and morphologic changes by protein kinase A activation via H2 receptors in human normal melanocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

A standardized protocol for assessing regulators of pigmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Purification and properties of tyrosinase inhibitor from mushroom

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Skin colour assessment in safety testing of cosmetics. An overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

In vivo spectroscopy in dermatology: methods and new fields of application

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Assessment of topical hypopigmenting agents on solar lentigines of Asian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

The validity and practicality of sun-reactive skin types I through VI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Utilization of a high-resolution digital imaging system for the objective and quantitative assessment of hyperpigmented spots on the face

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Development of a digital imaging system for objective measurement of hyperpigmented spots on the face

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

A New Formula for Depigmenting Human Skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Ochronosislike pigmentation from hydroquinone bleaching creams in American blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Enhancement of the depigmenting effect of hydroquinone and 4-hydroxyanisole by all-trans-retinoic acid (tretinoin): the impairment of glutathione-dependent cytoprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

The human glutathione S-transferase P1-1 gene: modulation of expression by retinoic acid and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Effect of L-ascorbic acid on the monophenolase activity of tyrosinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Linoleic acid and alpha-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Inhibition of melanosome transfer results in skin lightening

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

The Use of Chemical Peelings in the Treatment of Different Cutaneous Hyperpigmentations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-1alpha, interleukin-1beta, endothelin-1 and tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Analytic quantification of phototype-related regional skin complexion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Mechanism of inhibition of melanogenesis by hydroquinone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Studies on L-ascorbic acid derivatives. II. L-Ascorbic acid 3-phosphate and 3-pyrophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-2494.2003.00182.X

10.1046/J.1467-2494.2003.00182.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18494898